Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Banasavadi‐Siddegowda, Balveen Kaur, Toshihiko Shimizu et al.|Neuro-Oncology Advances|2022Cited by 13
EXTH-76. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDESarah Rivas, Yeshavanath Banasavadi-Siddegowda, Kimberly Rivera-Caraballo et al.|Neuro-Oncology|2022Cited by 1
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Research Square|2025Cited by 1
DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Neuro-Oncology|2025Cited by 1
DDRE-26. INHIBITION OF PRMT5 SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYesh Banasavadi, Balveen Kaur, Sriya Namagiri et al.|Neuro-Oncology|2021Cited by 0